Oxford Cannabinoid Technologies Holdings plc to conduct live presentations to retail investors
Oxford Cannabinoid Technologies Holdings plc (“OCTP”), the UK based pharmaceutical company focussed on developing cannabinoid-based prescription medicines approved by regulatory agencies, will be conducting live presentations to current and prospective retail investors next week, following its recent admission to trading on the Main Market of the London Stock Exchange.
Hosted by investment platform AJ Bell and its weekly magazine Shares on Tuesday 8 June, and by investors relations specialists Yellowstone Advisory on Thursday 10 June, these presentations will offer an opportunity for potential investors to learn about the Company and its ambitions and outlook for the year ahead.
The webinars will be hosted by AJ Bell/Shares magazine on Tuesday 8th June 2021 at 19.45, and by Yellowstone Advisory on Thursday 10 June 2021 at 13.00.
The online presentations are open to all existing and potential investors and registration is free. Questions can be submitted during the presentation and will be addressed at the end.
To register for both events, please go to:
AJ Bell/Shares - https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-080621
Yellowstone - https://www.yellowstoneadvisory.com/event-details/oxford-cannabinoid-technologies-plc-webinar
Oxford Cannabinoid Technologies Holdings plc 0203 034 2820
Dr John Lucas (CEO) John@oxcantech.com
Acuitas Communications 020 3848 2819
Simon Nayyar Simon.nayyar@acuitascomms.com
James Gittings James.gittings@acuitascomms.com